All In Biotech

Drug Trial Radar · NCT02741258

Mepitel Film Treatment for the Prevention and Cutaneous Toxicity Due to Radiotherapy

Mepitel Film vs Standard of Care for the Radiotherapy Prevention and Cutaneous Toxicity in Patients With Post-surgery Breast Cancer

Last checked: Nov 19, 2026Latest source record: Jul 5, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 164 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

164

Actual

Start

Oct 1, 2015

Primary completion

Dec 31, 2021

Study completion Dec 31, 2021

Sponsor

Lead sponsor
Dario ValcarenghiAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Apr 18, 2016

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized study, mepitel vs standard of care for the prevention and skin toxicity due to radiotherapy in patients with post-surgery breast cancer. Mepitel film will be placed on the skin of the patients just before the start of the radiotherapy and will be replaced once a week until the end of the radiotherapy. In case of skin toxicities mepitel film will be placed until resolution of toxicities.

Conditions

  • Post-surgery Radiotherapy

Interventions

  • Mepitel FilmDevice

    Placement of Mepitel Film to prevent skin toxicity

  • skin creamDrug

    cream to treat skin erythema due to radiotherapy

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Mepitel Film efficacy in treating skin toxicity evaluatet with Common Terminology Criteria for Adverse Events (CTCAE)Time frame: one week after start of radiotherapy

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Oncology Institute of Southern Switzerland

    Bellinzona, Switzerland

  • Institut für Radiotherapie Klinik Hirslanden

    Zurich, Switzerland

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.